Compare DVN & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DVN | WAT |
|---|---|---|
| Founded | 1971 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 29.3B |
| IPO Year | 1999 | 1996 |
| Metric | DVN | WAT |
|---|---|---|
| Price | $49.92 | $307.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 17 |
| Target Price | $49.60 | ★ $387.31 |
| AVG Volume (30 Days) | ★ 15.8M | 884.0K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 4.17 | ★ 10.76 |
| Revenue | ★ $17,188,000,000.00 | $3,165,286,000.00 |
| Revenue This Year | $14.33 | $104.66 |
| Revenue Next Year | $1.07 | $10.42 |
| P/E Ratio | ★ $11.87 | $28.31 |
| Revenue Growth | ★ 7.83 | 6.99 |
| 52 Week Low | $25.89 | $275.05 |
| 52 Week High | $52.71 | $414.15 |
| Indicator | DVN | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.15 | 50.67 |
| Support Level | $31.54 | $305.35 |
| Resistance Level | $52.71 | $308.16 |
| Average True Range (ATR) | 1.62 | 8.69 |
| MACD | -0.21 | 3.13 |
| Stochastic Oscillator | 55.52 | 96.27 |
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two-thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. If the merger with Coterra is successful, it will have a foothold in the gas-driven Appalachian Basin, as well. At the end of 2025, Devon reported net proved reserves of 2.4 billion barrels of oil equivalent, up from 2.2 billion in 2024. Net production averaged roughly 840,000 barrels of oil equivalent per day in 2025 at a ratio of 73% oil and natural gas liquids and 27% natural gas.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.